European Archives - Page 787 of 899 - European Medical Journal

Continue
March 2015

EMJ Respiratory 3 [ePrint] 2015

Postoperative respiratory failure (RF) is a common problem following all types of major surgery, and which has significant implications for morbidity…
EMJ
1 Mins
29th February 2016

Genes Could Be the Answer to Pain Prediction

INFLUENCE of osteoarthritis genetics may be key to pain sensitivity, according to a recent study following 122 patients with knee osteoarthritis. The…
EMJ
1 Mins
29th February 2016

Pain Persists in Treated Rheumatoid Arthritis Patients

NEW research has revealed that pain persists in >50% of rheumatoid arthritis (RA) patients treated with methotrexate for 3 months, even in those who…
EMJ
1 Mins
24th February 2016

Artificial Intelligence May Help Override Fearful Memories

SCIENTISTS have created a procedure that can remove specific fearful memories from the brain, which could be used as a new therapy for treating…
EMJ
3 Mins
23rd February 2016

First Patients Enrolled and Dosed in the Pivotal Trial of Phase 3 of the Immunotherapy Tedopi® for Advanced Non-Small Cell Lung Cancer

Paris, February 22nd, 2016, 6:30pm – OSE Pharma SA (ISIN: FR0012127173; Mnémo: OSE), an immunooncology company with a specific immunotherapy…
EMJ
2 Mins
22nd February 2016

Patient Enrolment Completed in US Phase IIb Study of GrassMATAMPL

Allergy Therapeutics (AIM:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today announces it has completed…
EMJ
1 Mins
22nd February 2016

The E. Coli Anchor: The Achilles Heel of Urinary Tract Infections

NEW vaccines could soon be developed to combat urinary tract infections (UTI), following research that has provided a detailed view of a spring-like…
EMJ
1 Mins
22nd February 2016

Prostate Cancer Discovery May Lead to New Cancer Treatment

AN EXCITING discovery highlighting a link between two prostate cancer treatments has provided the basis for a potential new therapy. In addition…
EMJ
20th February 2016

Overview of a Phase I study of ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Martin JS Dyer, MA, DPhil, FRCP, FRCPath from the University of Leicester, Leicester, UK, provides an overview of a Phase I study of ONO/GS-4059, a…
EMJ
2 Mins
19th February 2016

Norgine Launches XIFAXAN® 200mg (aifaximin-α) for the Treatment of Travellers Diarrhoea in Australia

LONDON, UK, Friday 19 February, 12:00 GMT: Norgine B.V. has today announced that XIFAXAN® 200mg is now available in Australia for the treatment of…